<DOC>
	<DOCNO>NCT01515124</DOCNO>
	<brief_summary>WISER Survivor one year weight loss exercise study sedentary breast cancer survivor overweight obese breast cancer relate lymphedema . There four group trial : exercise , weight loss , exercise weight-loss combine , control group . The purpose study test effect intervention lymphedema outcome , breast cancer recurrence quality life . The cost analysis sub-study - assess cost-effectiveness conduct WISER Survivor intervention also model impact WISER Survivor intervention extend time frame .</brief_summary>
	<brief_title>The Women In Steady Exercise Research ( WISER ) Survivor Trial</brief_title>
	<detailed_description />
	<mesh_term>Lymphedema</mesh_term>
	<criteria>breast cancer survivor overweight obese ( BMI 25 great ) must breast cancer relate lymphedema least 2 month posttreatment ( e.g . surgery , chemotherapy , radiotherapy ) upper limit time elapse diagnosis eligible age range lower upper limit . currently free cancer medical condition medication would prohibit participation exercise program would negatively impact ability test primary aim inability walk 6 minute unaided extremely obese ( body mass index great equal 50 kg/m2 ) plan additional ( e.g . curative reconstructive ) surgery study period selfreport weightlift within past year already engage 3 time weekly aerobic activity moderate intensity plan move away area next year current use weight loss medication ( OTC prescription ) selfreport alcohol substance abuse within past 12 month , include atrisk drinking ( current consumption 14 alcoholic drink per week ) weight loss great 10 % past 3 month history bariatric surgery woman pregnant</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lymphedema</keyword>
	<keyword>Strength training intervention</keyword>
	<keyword>Weight loss intervention</keyword>
	<keyword>Breast cancer recurrence</keyword>
	<keyword>Cost Effectiveness</keyword>
</DOC>